396 filings
8-K
ACST
Acasti Pharma Inc - Ordinary Shares
1 Apr 24
Regulation FD Disclosure
8:00am
8-K
ACST
Acasti Pharma Inc - Ordinary Shares
12 Feb 24
Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights
8:00am
8-K
ACST
Acasti Pharma Inc - Ordinary Shares
8 Jan 24
Departure of Directors or Certain Officers
7:30am
8-K
ACST
Acasti Pharma Inc - Ordinary Shares
15 Dec 23
Changes in Registrant's Certifying Accountant
7:30am
8-K
gikj0
13 Nov 23
Acasti Announces Second Quarter 2024 Financial Results and Business Highlights
12:00am
8-K
z23kfazs
23 Oct 23
Acasti Announces Dosing of First Patient in GTX-104 STRIVE-ON Trial
4:30pm
EFFECT
ahierq5rg
17 Oct 23
Notice of effectiveness
12:15am
424B3
g6wyvvbbgygzkxm gy
16 Oct 23
Prospectus supplement
4:31pm
UPLOAD
43ui12
12 Oct 23
Letter from SEC
12:00am
CORRESP
00fmv
12 Oct 23
Correspondence with SEC
12:00am
8-K
8xyaicr1j6co2q v7
11 Oct 23
Submission of Matters to a Vote of Security Holders
4:30pm
D
r1t7yap
10 Oct 23
$15.12 mm in equity / options / securities to be acquired, sold $7.50 mm, 4 investors
7:40am
8-K
4s09hz0l06p81w6p u9l
26 Sep 23
Acasti Announces $7.5 Million Private Placement Equity Financing
8:10am
S-8
zfh6on
25 Aug 23
Registration of securities for employees
5:01pm
DEFA14A
bsdufi9s
25 Aug 23
Additional proxy soliciting materials
4:21pm
8-K
sk0jqyusk mdyz0vtt
11 Aug 23
Acasti Announces First Quarter 2024 Financial Results and Business Highlights
7:31am